Agios Pharmaceuticals (AGIO) Cash from Operations Growth (3y) (2015 - 2026)
Agios Pharmaceuticals (AGIO) Cash from Operations Growth (3y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,140.12 Bn | 66,139.83 Bn | - | -5.07% |
| 2 | Nanobiotix | 1,912.79 Bn | 1,912.73 Bn | - | - |
| 3 | Akari Therapeutics | 1,022.34 Bn | 1,022.34 Bn | - | - |
| 4 | BeOne Medicines | 472.60 Bn | 467.81 Bn | 1.35 Bn | 33.08% |
| 5 | Vertex Pharmaceuticals | 122.34 Bn | 115.09 Bn | 2.59 Bn | 16.64% |
| 6 | Regeneron Pharmaceuticals | 70.14 Bn | 61.39 Bn | 3.31 Bn | -7.60% |
| 7 | Belite Bio | 62.79 Bn | 62.79 Bn | - | - |
| 8 | Argenx Se | 56.19 Bn | 51.00 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.50 Bn | 34.49 Bn | 959.66 Mn | 34.32% |
| 10 | Agios Pharmaceuticals | 2.23 Bn | 1.49 Bn | 19.43 Mn | -7.70% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -7.70% |
| Dec 31, 2025 | -13.29% |
| Sep 30, 2025 | -7.30% |
| Jun 30, 2025 | -1.28% |
| Mar 31, 2025 | -4.49% |
| Dec 31, 2024 | -16.56% |
| Sep 30, 2024 | 19.92% |
| Jun 30, 2024 | -1.70% |
| Mar 31, 2024 | -3.44% |
| Dec 31, 2023 | -203.93% |
| Sep 30, 2023 | 16.31% |
| Jun 30, 2023 | -29.36% |
| Mar 31, 2023 | 3.33% |
| Dec 31, 2022 | 10.92% |
| Sep 30, 2022 | 5.88% |
| Jun 30, 2022 | 5.57% |
| Mar 31, 2022 | 1.82% |
| Dec 31, 2021 | -4.27% |
| Sep 30, 2021 | -36.96% |
| Jun 30, 2021 | -0.79% |